drugset / Trial / NCT01489696

A Study to Evaluate Cardiovascular Interactions Between Mirabegron and Tamsulosin

NCT01489696

Phase 1 Completed 48 enrolled Astellas Pharma Inc
RandomizedCrossoverOpen-label

Summary

The study aims to compare blood pressure and pulse in male healthy subjects taking mirabegron and tamsulosin both alone and in combination.

Timeline

Start
2010-08
Primary completion
2011-02
Completion
2011-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Mirabegron Other / unclassified Oral
Subject Tamsulosin Other / unclassified Oral